News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
James Davis: Ide-cel vs cilita-cel in R/R multiple myeloma
James Davis/X
Feb 23, 2025, 10:27

James Davis: Ide-cel vs cilita-cel in R/R multiple myeloma

James Davis, Assistant professor & malignant hematology pharmacist at MUSC Hollings Cancer Center, shared an article by Doris K. Hansen, et al. on X:

“In lieu of a head-to-head trial comparing ide-cel and cilta-cel (which we will never get), check out our study in Journal of Clinical Oncology comparing these products in over 600 patients.

Congrats Doris Hansen, Krina Patel, Surbhi Sidana, Danai Dima, Charlotte B Wagner.”

Comparison of Standard-of-Care Idecabtagene Vicleucel and Ciltacabtagene Autoleucel in Relapsed/Refractory Multiple Myeloma.

Authors: Doris K. Hansen, et al.

James Davis: Ide-cel vs cilita-cel in R/R multiple myeloma

 

cancer CharlotteBWagner Ciltacabtagene Autoleucel Danai Dima Doris Hansen Doris K. Hansen fight against cancer Global fight against cancer idecabtagene vicleucel James Davis Journal of Clinical Oncology Krina Patel multiple myeloma MUSC Hollings Cancer Center OncoDaily Oncology Surbhi Sidana
Special Coverage
Blog
May 29, 2025, 16:26
Porscha Johnson: Two More Days Before Our Live Interactive Molecular Tumor Board at ASCO 2025
Blog
May 29, 2025, 16:16
From Targeted Therapies to Early Detection, Connect With SCRI at ASCO25 - Sarah Cannon Research Institute
Blog
May 29, 2025, 15:41
Meet The Translational and Therapeutic Research in Pancreatic Cancer Team at Cancer Research Centre of Marseille - AFRCP
Career
May 29, 2025, 15:32
Join University of Arizona Cancer Center at ASCO 2025 to Explore Oncology Job Opportunities
Blog
May 29, 2025, 15:10
FORwards Special Interest Group Webinar on Fear of Cancer Recurrence Featuring Expert Christine Maheu
Blog
May 29, 2025, 14:19
Anna Cabanes on ATOM Coalition's Milestone in Global Cancer Access Program at the Recent Workshop in Zambia
Insight
May 29, 2025, 14:15
New Biomarker May Guide Best Use of KRAS Inhibitors in Lung Cancer
Opinion
May 29, 2025, 13:47
Robin Zon and Andy Guinigundo Highlighted the Importance of Team Attendance at ASCO 2025
Blog
May 29, 2025, 13:35
Habib Nehmé Highlights Elekta’s Record Fourth Quarter and Global Teamwork
Opinion
May 29, 2025, 13:32
List of 10 ADC Presentations Not to Miss at the ASCO 2025 Curated by Paolo Tarantino and Raffaele Colombo
Blog
May 29, 2025, 13:16
Dana Bryson Highlights ACT for Children's Progress in Expanding Pediatric Cancer Access
Insight
May 29, 2025, 13:11
START and OneOncology Partner to Expand Access to Early-Phase Oncology Trials